# US 2026/0041819 A1 · Tunable, biocompatible, nanoparticle-crosslinked hyaluronic acid-type i collagen hydrogel using diels-alder click chemistry for regenerative medicine applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0041819 A1
- Document ID: US20260041819A1
- Status: Published application
- Kind: A1
- Application number: 19/289,671
- Filed: 2025-08-04
- Published: 2026-02-12
- Earliest claimed: 2024-08-12
- Assignees: Clarkson University
- Inventors: Bethany Almeida
- Web page: https://patentgrep.com/patent/US20260041819A1

## CPC

- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/48: with macromolecular fillers
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/414: Growth factors
- A61L 2300/43: Hormones, e.g. dexamethasone
- A61L 2300/624: Nanocapsules
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present disclosure provides a hydrogel composition for tissue engineering and regenerative medicine, including naturally derived polymers functionalized with furan groups and nanoparticles of poly(lactic-co-glycolic acid)-poly(ethylene glycol) copolymer functionalized with maleimide groups. Covalent crosslinking via a bioorthogonal Diels-Alder click reaction forms a tunable, biocompatible, and biodegradable three-dimensional network. The hydrogel composition mimics the extracellular matrix and offers adjustable mechanical properties, controlled biodegradation, and therapeutic agent delivery for applications such as cartilage regeneration and drug delivery.

## Claims

### Claim 1

A hydrogel composition comprising:
one or more naturally derived polymers functionalized with furan groups;
nanoparticles comprising a poly(lactic-co-glycolic acid)-poly(ethylene glycol) copolymer functionalized with maleimide groups;
wherein the furan groups and the maleimide groups are covalently crosslinked via a bioorthogonal Diels-Alder click reaction to form a three-dimensional hydrogel network.

### Claim 2 (depends on 1)

The hydrogel composition of claim 1, wherein said one or more naturally derived polymers comprise:
hyaluronic acid; and
type I collagen.

### Claim 3 (depends on 2)

The hydrogel composition of claim 2, wherein said hyaluronic acid has an average molecular weight between 500 kDa and 2 MDa.

### Claim 4 (depends on 2)

The hydrogel composition of claim 2, wherein said type I collagen is derived from a bovine tendon source.

### Claim 5 (depends on 1)

The hydrogel composition of claim 1, wherein said nanoparticles have an average hydrodynamic diameter between 50 nm and 200 nm.

### Claim 6 (depends on 5)

The hydrogel composition of claim 5, wherein said nanoparticles have a zeta potential between −25 mV and −5 mV.

### Claim 7 (depends on 1)

The hydrogel composition of claim 1, wherein said molar ratio of furan groups to maleimide groups is between 1:1 and 1:10.

### Claim 8 (depends on 1)

The hydrogel composition of claim 1, wherein the composition further comprises:
a therapeutic agent encapsulated within said nanoparticles.

### Claim 9 (depends on 8)

The hydrogel composition of claim 8, wherein said therapeutic agent is selected from the group consisting of:
kartogenin;
dexamethasone; and
transforming growth factor-β.

### Claim 10 (depends on 1)

The hydrogel composition of claim 1, wherein said hydrogel exhibits a compressive modulus between 0.5 kPa and 5 kPa.

### Claim 11 (depends on 1)

The hydrogel composition of claim 1, wherein said bioorthogonal Diels-Alder click reaction is conducted:
at 37° C.; and
at a pH of between 7.0 and 7.4.

### Claim 12 (depends on 1)

The hydrogel composition of claim 1, wherein said poly(lactic-co-glycolic acid) comprises a lactic acid to glycolic acid molar ratio of 50:50.

### Claim 13 (depends on 1)

The hydrogel composition of claim 1, wherein said polyethylene glycol has a molecular weight between 2 kDa and 5 kDa.

### Claim 14

A method for fabricating a hydrogel, the method comprising:
functionalizing one or more naturally derived polymers with furan groups;
fabricating nanoparticles comprising a poly(lactic-co-glycolic acid)-poly(ethylene glycol) copolymer functionalized with maleimide groups;
combining the furan-functionalized polymers and the maleimide-functionalized nanoparticles; and
covalently crosslinking the furan groups and the maleimide groups via a bioorthogonal Diels-Alder click reaction to form a three-dimensional hydrogel network.

### Claim 15 (depends on 14)

The method of claim 14, wherein the step of functionalizing one or more naturally derived polymers with furan groups comprises:
reacting hyaluronic acid with furfurylamine in the presence of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM).

### Claim 16 (depends on 14)

The method of claim 14, wherein the step of functionalizing one or more naturally derived polymers with furan groups comprises:
reacting type I collagen with furfurylglycidyl ether under basic pH conditions.

### Claim 17 (depends on 14)

The method of claim 14, wherein the step of fabricating nanoparticles comprises:
activating carboxylic acid end groups of poly(lactic-co-glycolic acid) with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS); and
conjugating the activated poly(lactic-co-glycolic acid) to amine-terminated poly(ethylene glycol)-maleimide.

### Claim 18 (depends on 17)

The method of claim 17, wherein the step of fabricating nanoparticles further comprises:
dissolving the poly(lactic-co-glycolic acid)-poly(ethylene glycol)-maleimide copolymer in acetonitrile and introducing the solution into an aqueous phase to form nanoparticles by nanoprecipitation.

### Claim 19 (depends on 14)

The method of claim 14, wherein the step of covalently crosslinking the furan groups and the maleimide groups via a bioorthogonal Diels-Alder click reaction is conducted at 37° C. and at a pH of between 7.0 and 7.4.

### Claim 20 (depends on 14)

The method of claim 14, wherein the nanoparticles have an average hydrodynamic diameter between 50 nm and 200 nm.

### Claim 21 (depends on 14)

The method of claim 14, wherein the hydrogel further comprises a therapeutic agent encapsulated within the nanoparticles.

### Claim 22 (depends on 21)

The method of claim 21, wherein the therapeutic agent is selected from the group consisting of:
kartogenin;
dexamethasone; and
transforming growth factor-β.

### Claim 23 (depends on 14)

The method of claim 14, wherein the molar ratio of furan groups to maleimide groups is between 1:1 and 1:10.

### Claim 24 (depends on 14)

The method of claim 14, wherein the hydrogel exhibits a compressive modulus between 0.5 kPa and 5 kPa.
